Lung cancer is the second-most common cancer and the leading cause of cancer death in the United States. Over 80% of lung ...

New clinical evidence indicates that a widely used supplement may alter gut microbes involved in vitamin D biology and ...

Genetic alterations lie at the heart of cancer development, but scientists may have been overlooking a powerful driver of these changes—the everyday nutrients that feed our cells.

Mucommune, a Morrisville-based biotechnology company with roots at the University of North Carolina at Chapel Hill, has been ...

PanCAN Chief Scientific & Medical Officer Dr. Anna Berkenblit Looks Back at Pancreatic Cancer in 2025: A Year of Progress, ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. On the regional level, as the Human Development Index ...

Researchers at Baylor College of Medicine and collaborating institutions have uncovered new potential therapeutic targets for cancer and new insights into existing cancer drug targets, expanding the ...

Most cancer genome studies have focused on mutations in the tumor itself and how such gene variants allow a tumor to grow unchecked. A new study, led by researchers at Washington University School of ...

Dr Catherine Elliott of Cancer Research UK explores how vaccine advances could transform cancer prevention and treatment ...

Shilpa S. Murthy, an Indian American early career investigator at Yale Cancer Center has been awarded a prestigious $1.1 ...

Cancer cases are constantly increasing, including nasal cancer. Let us explain the symptoms of nasal cancer and how you can ...